SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD

Review checklist: Eva Perón (HR-ML025)
All records · Back to the record · Dossier (sources.md) · Terminology · Report a problem · Comments
Everything a reviewer needs to judge, gathered from the record. Release status: draft.
- 18judgment calls in the dossier
- 1protocol deviations
- 3orders and referrals without results in the record
- 3evidence items to check (retrospective or sensitive claims, unconfirmed diagnoses)
Review status
| Review | Status | Reviewer | Date | Notes |
|---|
| schema validation | not_started | | | Run scripts/build.ps1 -Conformance. |
| clinical review | not_started | | | Awaiting clinician review; check direct biopsy of a visible lesion, FIGO 2018 stage IIB by MRI and PET-CT, chemoradiation with weekly cisplatin and brachytherapy within eight weeks, the fertility counseling and her decision, estradiol with progesterone for radiation-induced menopause with the uterus in place, and the documentation of disclosure. |
| provenance review | not_started | | | Lawrence K. Altman's newspaper report of Barron Lerner's Lancet article (Tampa Bay Times, 2000), the Gale Women in World History entry, and two PubMed abstracts by Nijensohn logged; Lerner's Lancet article itself is cited without its text. The illness claims are D with certainty probable because they rest on Lerner's research as reported; the lobotomy is R, possible. |
| safe messaging review | not_started | | | The reported lobotomy is recorded once, as history only, marked sensitive, without detail, and is not carried into the modern episode. Political material is limited to what identifies her and explains the secrecy. No modern role is given to any real person. |
Judgment calls (dossier editorial resolutions)
- Recent-death rule. She died in 1952, so the rule does not apply. Even so, claims are limited to what the fetched sources state; political material is limited to her identity and the reason given for the secrecy.
- Source quality. Much of what is written online about her illness is in popular-history sites, blogs, and mirrors that repeat one another. Only a physician-journalist’s newspaper report of Lerner’s research, a Gale reference encyclopedia, and PubMed records were used. Lerner’s Lancet article itself has no abstract and was not read; its findings are taken from item 1. Biographies (for example by Navarro and Fraser) and Argentine medical records were not consulted.
- Grading. Her birth, marriage, public role and death are D, confirmed. The illness and its concealment (CLM-0003 to CLM-0006) are D with certainty “probable”, because they rest on one historian’s research as reported in a newspaper and the governments had not confirmed them. Lerner’s reading of what the case shows about medical ethics (CLM-0009) is R, probable.
- Lobotomy. The study by Nijensohn and colleagues (published online in 2011) and the author’s later paper are recorded once, in CLM-0008, as R with certainty “possible”, marked sensitive, without detail, as history only. The evidence is indirect (memoirs, interviews, radiographs, photographs). It is not carried into the modern episode, which records no neurosurgical procedure and no psychiatric diagnosis.
- Not verified, left out. The following were found only in unreliable sources and are not claimed: that the cancer had spread widely at the first operation; the radium dose or the type of chemotherapy; the specific names and roles of Argentine physicians other than as reported in item 4; details of her last months; and accounts of what happened to her body after death. The cause of death of Juan Perón’s first wife, mentioned in item 1, is not recorded, because she was not a relative.
- Birth and death dates. May 7, 1919 is from the Gale encyclopedia, which notes that her marriage contract gave 1922 (recorded as a superseded alternative). July 26, 1952 is from both sources; another online encyclopedia gives July 16, which was not adopted.
- Index age and dates. The index visit on February 9, 2026 maps to February 9, 1951, when she was 31: after the documented anemia and vaginal bleeding of 1950 and before the documented diagnosis in August 1951, so the presenting problem matches the known history and the intake documents show no later events. The synthetic date of birth is May 7, 1994 (shift 75 years). The visits on February 17, March 2, May 18, and August 17, 2026, the sick visit on March 27, 2026, the preventive visit on September 21, 2026, and the treatment dates (March 9 to May 4, 2026) map to the same days of 1951, before her death. The modern diagnosis, earlier than the historical one, and the modern treatment are synthetic and are not a claim about what happened in 1951.
- Disclosure, the teaching contrast. Historically the diagnosis was kept from her. In the modern episode she is asked at intake how she wants results given; the biopsy result is given to her first, in person, in Spanish, with time set aside, after asking how much she wants to know; the consultant explains staging, treatment and fertility to her directly through a professional interpreter; she decides who else is told; and no relative or other person is given information or a role. The record documents this at the second, third and fifth visits and in the consultation, and in her advance care planning.
- Language and culture. Her preference for Spanish, the Spanish-speaking primary clinician, the professional medical interpreter for the consultant, her refusal of family interpreters, written materials in Spanish, and the offer of spiritual care are synthetic choices.
- Screening history. “Never screened” and “not vaccinated against HPV” are synthetic, in line with the documented fact that the Pap smear was not standard care in 1950 (CLM-0010).
- Real people. Juan Perón, George Pack, Barron Lerner and the neurosurgeons named in the sources appear only in the claims. No modern decision, statement, or health fact is attributed to any real person; her spouse, family, friend, colleague and health care agent in the modern episode are unnamed and have no role. The aliases “Eva María Ibarguren” and “Evita” appear in no other record.
- Presenting problem. Abnormal bleeding with a visible cervical mass (N93.8) is the presenting problem at intake, resolved at the consultation on February 17, 2026, when the biopsy result was given and squamous cell carcinoma of the cervix (C53.9) was recorded. The FIGO 2018 stage (IIB) was assigned at the third visit after MRI and PET-CT. The intake documents state only what was known then.
- Modern management. Definitive chemoradiation (45 Gy in 25 fractions with five weekly doses of cisplatin 40 mg/m2) followed by four fractions of image-guided high-dose-rate brachytherapy, completed within eight weeks; anemia corrected with oral iron; acetaminophen rather than anti-inflammatory painkillers; fertility counseling before treatment, after which she declined egg freezing and ovarian transposition; radiation-induced ovarian failure (E89.41) treated with estradiol and progesterone; a vaginal dilator; complete metabolic response on PET-CT at three months. Pembrolizumab and induction chemotherapy were not discussed in the record because the guideline text on them was not reviewed.
- Sick visit. A same-day visit for acute cystitis (N30.00) in the third week of chemoradiation, chosen because it is common in pelvic radiation, must be told apart from radiation cystitis, and requires checks of the neutrophil count and kidney function before nitrofurantoin; it insinuates no undocumented real diagnosis.
- Preventive visit. A periodic adult preventive visit at age 32, after treatment (CPT 99395 and 99497 in plain text): PHQ-2 0, AUDIT-C 1, cervical screening replaced by surveillance, HIV and hepatitis C up to date, influenza vaccine given, HPV vaccine declined after a shared decision, bone health, and advance care planning in Spanish with an unnamed agent, recording that she always wants to be told the truth herself.
- Focused visits. The four chronic-care follow-ups (diagnosis and consultation, staging, end of treatment, three months after) are documented as focused visits on the NCCN guideline, FIGO 2018, the ASCO communication, fertility and anxiety and depression guidelines, and the CMID anemia monograph. One deviation is recorded instead of an invented result: the mid-treatment PHQ-9 and GAD-7 were not done; scores fell from diagnosis to the end of treatment, no harm resulted, and the social worker now records them at the mid-treatment review.
- Consultation. The gynecologic oncology referral and the consultation by Henrietta Osei-Bonsu, MD (a fictional consultant), on the day the biopsy result was given, are S. The consultant answers the five referral questions in line with what the record shows afterwards: squamous cell carcinoma, at least stage IIB, staged by MRI and PET-CT (confirmed IIB); chemoradiation rather than surgery (given as recommended); fertility options and their time needed (she declined them); iron, acetaminophen and weekly blood tests (done); and direct disclosure in Spanish with the people she chooses (done). The consultant’s recommended mid-treatment mood measures were missed and are recorded as the deviation.
- Synthetic content. All visits, laboratory values, scores, biopsy, imaging and PET-CT findings, vital signs, medicines and doses, her height (165 cm), her modern work, language and family situation are synthetic. The HPV, cytology, pregnancy, HIV, hepatitis C and urine culture results, and the MRI and PET-CT reports, appear only in the note text.
Protocol deviations
Checks the monitoring protocol called for that the schedule did not perform. Each is recorded with its outcome and corrective action, never filled with an invented result.
| Visit | Measure | Interval | What happened |
|---|
2026-05-18 Progress note 05 (C-CDA) | PHQ-9 and GAD-7 | At diagnosis, before treatment, at mid-treatment, at the end of treatment, and in follow-up | PHQ-9 7 and GAD-7 6 today. The mid-treatment measures were not done: the only visit here during treatment was the sick visit for cystitis, and the weekly oncology reviews did not record them. No harm resulted: scores fell from diagnosis to today, and the social worker saw her weekly. Corrective action: the social worker now records the PHQ-9 and GAD-7 at the mid-treatment review |
Orders and referrals without results in the record
Evidence to check
Retrospective claims (R)
| Claim | Statement | Certainty |
|---|
| CLM-0008 | A study by Nijensohn and colleagues, published online in 2011, reported evidence that she underwent a prefrontal lobotomy in Buenos Aires in the last months of her illness, for pain, anxiety and agitation from metastatic cancer; the evidence includes a neurosurgeon's memoirs and press interviews, accounts of people close to her, and skull radiographs. A later paper by the same author argued that the operation was also meant to change her behavior. | possible |
| CLM-0009 | The medical historian Barron Lerner, who reported the case in The Lancet in 2000, said it showed how far medical practice and ethics have changed: patients with cancer were then rarely told what they had, whereas most patients in the United States are now told their diagnosis. | probable |
Sensitive claims
| Claim | Grade | Statement |
|---|
| CLM-0008 | R | A study by Nijensohn and colleagues, published online in 2011, reported evidence that she underwent a prefrontal lobotomy in Buenos Aires in the last months of her illness, for pain, anxiety and agitation from metastatic cancer; the evidence includes a neurosurgeon's memoirs and press interviews, accounts of people close to her, and skull radiographs. A later paper by the same author argued that the operation was also meant to change her behavior. |
Diagnoses not confirmed
None.
Notes to read
Every note in the record, with its type. All clinical content is synthetic.
Abnormal results
| Date | Result | Value | Flag |
|---|
| 2026-02-09 | Hemoglobin | 9.4 g/dL (low) | Low |
| 2026-02-09 | Mean cell volume | 72 fL (low) | Low |
| 2026-02-09 | Ferritin | 6 ng/mL (low) | Low |
| 2026-03-02 | Hemoglobin | 10.2 g/dL (low) | Low |
| 2026-03-02 | Mean cell volume | 77 fL (low) | Low |
| 2026-05-18 | Hemoglobin | 11.2 g/dL (low) | Low |
| 2026-03-27 | Hemoglobin | 10.4 g/dL (low) | Low |
| 2026-05-18 | FSH | 72 m[IU]/mL (high) | High |
| 2026-05-18 | Estradiol | 14 pg/mL (low) | Low |